Research is at the heart of advances in treatment and care for Duchenne muscular dystrophy and funding Duchenne research is a core objective for Parent Project Muscular Dystrophy (PPMD). PPMD’s research programs, which run the gamut from small bridge grants to seven figure awards for drug development, are all designed to fund projects directly aimed at the development of new therapies for Duchenne.
Applications to PPMD are reviewed by either:
PPMD uses an online grant submission and management system to reduce the burden of paper and to standardize our procedures. View our available funding opportunities below, and then click the “Apply for Funding” button.
Current Funding Opportunities
- Request for Applications: Beyond Exon 51
PPMD announces that it will fund up to $1M in projects by mid-2014 focused on the development of oligos or other techniques to skip exons that are not currently in clinical development, or for multi-exon skipping projects, including the skipping of duplications. Learn More & Apply...
Deadlines and Dates
RFA Released: August 9, 2013
Applications Due: September 13, 2013
Reviews Due: November 15, 2013
Review Responses Due: November 30, 2013
Funding Start: January 15, 2014
- COMING SOON
RFA for late stage pre-clinical and early stage clinical therapeutics projects for Duchenne.
Exploratory Awards, Investigator Awards and End Duchenne Awards will be considered again next year. Deadlines will be released at the start of 2014.
Rapid and open sharing of new research data, analyses, and ideas. PLoS Currents: Muscular Dystrophy enables research results and ideas to be shared immediately while ensuring that they will be permanently archived and citable. PLoS Currents provides open access to all content, ensuring that authors reach the widest possible audience. All content is reviewed by a group of expert researchers. PPMD is proud to provide support to launch and maintain PLoS Currents: Muscular Dystrophy.
In this section
Apply for Funding
End Duchenne Grant Award Program
GIFTED: Drug Development Grant
PPMD Investigator Award
PPMD Bridge/Pilot Funds